Sanofi Q3 2012 - Interview With CFO Jérôme Contamine

Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2012. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and outlook.

Click to watch the video:

Topics covered in the interview include:

- Q3 2012 Results- Diabetes- Multiple Sclerosis- Rare Diseases- Vaccines- Austerity in Europe- Emerging Markets- R&D pipeline

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Company website:

Copyright Business Wire 2010